TransCode Therapeutics Receives Notice of Award from National Institutes of Health (NIH) for Third Year of Grant to Support Clinical Evaluation of TTX-MC138

BOSTON, April 05, 2023 -- TransCode Therapeutics, Inc. , the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that it has been... | April 5, 2023

Related Keywords

Boston ,Massachusetts ,United States ,Michael Dudley ,Alan Freidman ,Nasdaq ,Oncology Company ,Transcode Therapeutics Inc ,Small Business Innovation Research ,Exchange Commission ,Code Therapeutics ,Fast Track Small Business Innovation Research ,Chief Executive Officer ,Institutional Review Board ,Transcode Therapeutics ,Private Securities Litigation Reform Act ,Investigational New Drug ,Annual Report ,Nc Stock Exchange ,News ,Information ,Press Release ,Pril ,023 ,Transcode ,The ,Na ,Ncology ,O ,More ,Ffectively ,Reating ,Dancer ,Sing ,Oday ,Nnounced ,Hat ,It ,As Rnaz Us89357l1052 ,